Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 5 Stomach Neoplasms 1 Sarcoma, Ewing 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neoplasms 1 Neoplasm Metastasis 1 Endometrial Neoplasms 1 Desmoid Tumors 1 Craniopharyngioma 1 Colorectal Cancer Metastatic 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Breast Neoplasms 1 Anal Cancer Metastatic 1 Adenomatous Polyposis Coli 1

Interventions

Fulvestrant 34 Specimen Handling 31 Letrozole 30 Paclitaxel 23 pembrolizumab 19 Carboplatin 19 ribociclib 18 exemestane 18 Capecitabine 17 Trastuzumab 16 Tamoxifen 16 Magnetic Resonance Spectroscopy 16 palbociclib 15 Anastrozole 15 Biopsy 14 trastuzumab deruxtecan 13 abemaciclib 13 pertuzumab 11 Radiotherapy 11 Cyclophosphamide 9 inavolisib 8 elacestrant 8 olaparib 7 Taxes 7 Standard of Care 7 Radiation 7 Mastectomy, Segmental 7 Goserelin 7 130-nm albumin-bound paclitaxel 7 giredestrant 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × trifluridine tipiracil drug combination × 30 days × Clear all

NCT04489173 2026-05-22

TIBET

Borstkanker Onderzoek Groep

Phase 2 Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡